CNS Involvement in primary Sjögren syndrome: Assessment of gray and white matter changes with MRI and voxel-based morphometry

American Journal of Roentgenology

Volumn 197, Issue 5, 2011, Pages 1207-1212

  Tzarouchi, Loukia C ^a   Tsifetaki, Niki ^a   Konitsiotis, Spyridon ^a   Zikou, Anastasia ^a   Astrakas, Loukas ^a   Drosos, Alexandros ^a   Argyropoulou, Maria I ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

CNS; Gray matter; MRI; Sj gren syndrome; White matter

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE DURATION; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; AGED; BRAIN DISEASES; BRAIN MAPPING; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC;

EID: 80054932300     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5984     Document Type: Article

References (37)

1. Fox RI, Howell FV, Bone RC, Michelson P. Primary Sjögren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum 1984; 14:77-105 (Pubitemid 15218505)
2. Soliotis FC, Mavragani CP, Moutsopoulos HM. Central nervous system involvement in Sjögren's syndrome. Ann Rheum Dis 2004; 63:616-620 (Pubitemid 38658387)
3. Alexander EL, Provost TT, Stevens MB, Alexander GE. Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) 1982; 61:247-257 (Pubitemid 12039759)
4. Alexander E. Central nervous system disease in Sjögren's syndrome: new insights into immunopathogenesis. Rheum Dis Clin North Am 1992; 18:637-672
5. Drosos AA, Andonopoulos AP, Lagos G, Angelopoulos NV, Moutsopoulos HM. Neuropsychiatric abnormalities in primary Sjögren's syndrome. Clin Exp Rheumatol 1989; 7:207-209 (Pubitemid 19136962)
6. Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005; 128:2518-2534 (Pubitemid 41552938)
7. Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjögren's syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 2004; 34:623-630 (Pubitemid 39643125)
8. Coates T, Slavotinek JP, Rischmueller M, et al. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. J Rheumatol 1999; 26:1301-1305 (Pubitemid 29268082)
9. Alexander EL, Beall SS, Gordon B, et al. Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. Ann Intern Med 1988; 108:815-823
10. Pierot L, Sauve C, Leger JM, et al. Asymptomatic cerebral involvement in Sjögren's syndrome: MRI findings of 15 cases. Neuroradiology 1993; 35:378-380 (Pubitemid 23151953)
11. Mataró M, Escudero D, Ariza M, et al. Magnetic resonance abnormalities associated with cognitive dysfunction in primary Sjögren syndrome. J Neurol 2003; 250:1070-1076 (Pubitemid 37152556)
12. Belin C, Moroni C, Caillat-Vigneron N, et al. Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT. Ann Med Interne (Paris) 1999; 150:598-604 (Pubitemid 30056872)
13. Kao CH, Ho YJ, Lan JL, ChangLai SP, Chieng PU. Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome. J Nucl Med 1998; 39:1354-1356
14. Huang WS, Chiu PY, Kao A, Tsai CH, Lee CC. Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain: a preliminary report. Rheumatol Int 2003; 23:174-177 (Pubitemid 36960494)
15. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14:21-36 (Pubitemid 32552740)
16. Tzarouchi LC, Astrakas LG, Kontsiotis S, et al. Voxel-based morphometry and voxel-based relaxometry in parkinsonian variant of multiple system atrophy. J Neuroimaging 2010; 20:260-266
17. Astrakas LG, Argyropoulou MI. Shifting from region of interest (ROI) to voxel-based analysis in human brain mapping. Pediatr Radiol 2010; 40:1857-1867
18. Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage 2001; 14:1238-1243 (Pubitemid 33124172)
19. Argyropoulou MI, Tsifetaki N, Zikou AK, et al. Systemic sclerosis: brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging. Arthritis Rheum 2006; 54:1350-1352 (Pubitemid 43672949)
20. Alexander EL, Ranzenbach MR, Kumar AJ, et al. Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 1994; 44:899-908
21. Govoni M, Bajocchi G, Rizzo N, et al. Neurological involvement in primary Sjögren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol 1999; 18:299-303 (Pubitemid 29369541)
22. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28:652-659 (Pubitemid 27118393)
23. Alexander EL. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle - a clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 1993; 19:869-908 (Pubitemid 23347416)
24. Wen W, Sachdev P, Shnier R, Brodaty H. Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI. Neuroimage 2004; 21:1350-1356 (Pubitemid 38446563)
25. DeCarli C, Murphy DG, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995; 45:2077-2084
26. Takahashi W, Takagi S, Ide M, Shohtsu A, Shinohara Y. Reduced cerebral glucose metabolism in subjects with incidental hyperintensities on magnetic resonance imaging. J Neurol Sci 2000; 176:21-27 (Pubitemid 30365006)
27. Wen W, Sachdev PS, Chen X, Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 2006; 29:1031-1039 (Pubitemid 43184167)
28. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83:280-291 (Pubitemid 39258414)
29. Kadota Y, Tokumaru AM, Kamakura K, et al. Primary Sjögren's syndrome initially manifested by optic neuritis: MRI findings. Neuroradiology 2002; 44:338-341 (Pubitemid 36097181)
30. Tesar JT, McMillan V, Molina R, Armstrong J. Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome. Am J Med 1992; 92:686-692
31. Sasaki T. An autopsy case of Sjögren's syndrome with a clinical course resembling multiple sclerosis [in Japanese]. Saishin Igaku 1976; 31:1394-1401
32. Appenzeller S, Bonilha L, Rio PA, Min Li L, Costallat LT, Cendes F. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. Neuroimage 2007; 34:694-701 (Pubitemid 44827765)
33. Black SE, Moffat SD, Yu DC, Parker J, Stanchev P, Bronskill M. Callosal atrophy correlates with temporal lobe volume and mental status in Alzheimer's disease. Can J Neurol Sci 2000; 27:204-209
34. Hampel H, Teipel SJ, Alexander GE, et al. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol 1998; 55:193-198
35. Leys D, Pruvo JP, Parent M, et al. Could wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 1991; 54:46-50
36. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004; 63:246-253 (Pubitemid 38971122)
37. Tien RD, Ashdown BC. Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms, and supratentorial diseases in 26 patients. AJR 1992; 158:1155-1159